I'm fine.Even when you see news about colorectal cancer, do you think that and close the screen?My stomach doesn't hurt. I'm ...

Nervous about getting a colonoscopy? A gastroenterologist answers six common questions about prep, the procedure, and what to expect.

We know that a colonoscopy is the most effective tool for the early detection and prevention of colon cancer. But anyone who has ever had a colonoscopy also knows that it's not necessarily something ...

Among 100,000 people who receive a colonoscopy every 10 years, 1,543 would develop colorectal cancer and 672 would die from the disease, they determined. For stool-based tests every one to three years ...

Michal F Kaminski and colleagues report that colonoscopy screening reduced colorectal cancer incidence, but not mortality, during a 13-year follow-up.1 The response from the public health field will ...

A recent study published in JAMA identified colorectal cancer as the leading cause of cancer-related deaths among Americans ...

Colorectal cancer screening is crucial for early detection and prevention, with colonoscopy remaining the most effective method. Newer, noninvasive options like stool tests and blood tests offer ...

The American Cancer Society now recommends stool-based tests and a blood test as alternatives to colonoscopy for colorectal cancer screening. Colonoscopy remains the gold standard for screening ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...

A Vancouver man diagnosed with colon cancer at 35 built his own screening test — and his story shows why younger Canadians ...

We thank João Martins and Aneel Bhangu, Hermann Brenner and colleagues, and Uri Ladabaum and colleagues for their interesting comments on our report from the NordICC trial.1 We agree with Martins and ...